UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Variations in internal standard: an inspector's perspective

Bioanalysis, 2019-09, Vol.11 (18), p.1649

Vinter, Stephen

2019

Link zum Volltext

Verfügbarkeit prüfen

Conduct of remote inspections: challenges and progress

Bioanalysis, 2021-12, Vol.13 (24), p.1789

2021

Link zum Volltext

Verfügbarkeit prüfen

Crucial importance of evaluating internal standards (IS) response and troubleshooting in effective LCMS method development, validation and sample analysis

Bioanalysis, 2019-09, Vol.11 (18), p.1645

2019

Link zum Volltext

Verfügbarkeit prüfen

Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UK

Clinical pharmacology and therapeutics, 2022-07, Vol.112 (1), p.31-43

2022

Link zum Volltext

Verfügbarkeit prüfen

Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop

Clinical pharmacology and therapeutics, 2020-11, Vol.108 (5), p.949-963

2020

Link zum Volltext

Verfügbarkeit prüfen

2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & Part 1B - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)

Bioanalysis, 2022-05, Vol.14 (9), p.505

2022

Link zum Volltext

Verfügbarkeit prüfen

2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)

Bioanalysis, 2017-11, Vol.9 (22), p.1807

2017

Link zum Volltext

Verfügbarkeit prüfen

2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)

Bioanalysis, 2018-12, Vol.10 (23), p.1897

2018

Link zum Volltext

Verfügbarkeit prüfen

2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)

Bioanalysis, 2018-11, Vol.10 (22), p.1781

2018

Link zum Volltext

Verfügbarkeit prüfen

2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs ( Part 2 - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)

Bioanalysis, 2019-12, Vol.11 (23), p.2099

2019

Link zum Volltext

Verfügbarkeit prüfen

2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A - Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy a

Bioanalysis, 2023-08, Vol.15 (16), p.955

2023

Link zum Volltext

Verfügbarkeit prüfen

Functional addressing in Gutenberg: Interprocess communication without process identifiers

IEEE transactions on software engineering, 1986-11, Vol.SE-12 (11), p.1056-1066

1986

Link zum Volltext
Volltext

Managing the transition to OSF DCE security

DCE — The OSF Distributed Computing Environment Client/Server Model and Beyond, 2005, p.147-161

2005

Link zum Volltext

Verfügbarkeit prüfen

Cronus: a distributed computing environment

[1989] Proceedings. The Annual AI Systems in Government Conference, 1989, p.314

Vinter, S.

1989

Link zum Volltext
Volltext

Extended discretionary access controls

Proceedings. 1988 IEEE Symposium on Security and Privacy, 1988, p.39-49

Vinter, S.T.

1988

Link zum Volltext
Volltext

Privilege transfer and revocation in a port-based system

IEEE transactions on software engineering, 1986-05, Vol.SE-12 (5), p.635-648

1986

Link zum Volltext
Volltext

A secure distributed operating system

Proceedings. 1988 IEEE Symposium on Security and Privacy, 1988, p.27-38

1988

Link zum Volltext
Volltext

Classification and characteristics of on‐label and off‐label apixaban use in Denmark and Sweden

Pharmacoepidemiology and drug safety, 2019-06, Vol.28 (6), p.867-878

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis

JAMA neurology, 2021-01, Vol.78 (1), p.102

2021

Link zum Volltext

Verfügbarkeit prüfen

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Nature genetics, 2012-12, Vol.44 (12), p.1349-1354

2012

Link zum Volltext

Verfügbarkeit prüfen

Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men

Neurology, 2009-10, Vol.73 (16), p.1292

2009

Link zum Volltext

Verfügbarkeit prüfen

Factors affecting brain structure in men with HIV disease in the post-HAART era

Neuroradiology, 2012-02, Vol.54 (2), p.113-121

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(24)
Humans
(18)
Chemistry
(12)
Physical Sciences
(12)
Biochemical Research Methods
(11)
Biochemistry & Molecular Biology
(11)
Chemistry, Analytical
(11)
Male
(11)
Biological And Medical Sciences
(7)
Biomarkers - Analysis
(7)
Medical Sciences
(7)
Female
(6)
Middle Aged
(6)
Human Immunodeficiency Virus
(5)
Infectious Diseases
(5)
Mass Spectrometry
(5)
Neurosciences & Neurology
(5)
Operating Systems
(5)
Antiretroviral Therapy, Highly Active
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Variations in internal standard: an inspector's perspective

Conduct of remote inspections: challenges and progress

Crucial importance of evaluating internal standards (IS) response and troubleshooting in effective LCMS method development, validation and sample analysis

Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UK

Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop

2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)

2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)

2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 - hybrid LBA/LCMS and input from regulatory agencies)

2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs ( Part 2 - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies)

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS)

Functional addressing in Gutenberg: Interprocess communication without process identifiers

Managing the transition to OSF DCE security

Cronus: a distributed computing environment

Extended discretionary access controls

Privilege transfer and revocation in a port-based system

A secure distributed operating system

Classification and characteristics of on‐label and off‐label apixaban use in Denmark and Sweden

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men

Factors affecting brain structure in men with HIV disease in the post-HAART era

Suchergebnisse filtern